Scarica l'app Stockscreener
6.67
5.66%
-0.40
Dopo l'orario di chiusura:
6.58
-0.09
-1.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
Novavax told by FDA to conduct additional study for COVID vaccinereport - Seeking Alpha
Press Release Distribution & PR Platform - ACCESS Newswire
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial - Bloomberg.com
FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports - Reuters
Exclusive | FDA Asks Vaccine Maker to Complete New Clinical Trial for Delayed Covid-19 Shot - WSJ
Novavax COVID Vaccine Moves Closer to Full FDA Approval - yoursun.com
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
An Approvable Protein-Based COVID-19 Vaccine - Vax-Before-Travel
Novavax up 20% on ‘approvable’ COVID-19 vaccine development - The Pharma Letter
As FDA delays Novavax' COVID vaccine approval, patients fight back - Reuters
Novavax Jumps After FDA Asks for More Data on Its Covid Vaccine - MSN
As FDA delays Novavax’ COVID vaccine approval, patients fight back - Bilyonaryo Business News
Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance
Novavax (NVAX) Rises Amid FDA Data Request for COVID-19 Vaccine - GuruFocus
Novavax Says Its COVID Shot Is on Track for Full FDA Approval After Delay - MSN
Postmarketing Surprise Is Latest Plot Twist For Novavax’s COVID-19 Vaccine BLA - insights.citeline.com
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax: New COVID-19 Vaccine on Track for FDA Approval - Inc.com
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps - Benzinga
Novavax Highlights Technology Platform and Matrix-M® Adjuvant Potential at World Vaccine Congress - Novavax
Novavax Shares Surge 17% as FDA Requests Postmarketing Data for COVID-19 Vaccine - Yahoo Finance
Novavax shares soar after FDA request raises hope for COVID vaccine approval - Reuters
Sector Update: Health Care - marketscreener.com
Vaccine Makers Fall After RFK Jr. Says Some Shots Don’t Work - MSN
FDA asks Novavax for post-approval data on COVID vaccine, shares soar - marketscreener.com
Novavax's stock surges on 'good news' from Food and Drug Administration - The Business Journals
Novavax shares rise as FDA signals path to COVID vaccine approval - Proactive Investors
Vertiv earnings beat, DOJ & Disney–fuboTV deal, Novavax COVID shot - Yahoo Finance
Novavax says its COVID-19 shot is on track for full FDA approval after delay - MSN
Novavax (NVAX) Stock Soars After FDA Seeks More Data on COVID Vaccine - GuruFocus
FDA asks Novavax for post-approval data on COVID vaccine, raising hopes for green light - marketscreener.com
Novavax up on FDA's request for additional data for COVID-19 shot - MSN
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers By Stocktwits - Investing.com India
Novavax up on FDA's request for additional COVID-19 shot data (NVAX:NASDAQ) - Seeking Alpha
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - MSN
Amphenol Posts Better-Than-Expected Results, Joins SAP, Tesla, Pegasystems And Other Big Stocks Moving Higher On Wednesday - Benzinga
Novavax (NVAX) Sees Stock Surge Following FDA Communication on Nuvaxovid | NVAX Stock News - GuruFocus
Novavax Signals Chances Of FDA Approval For Its COVID-19 Vaccine: But Retail Sentiment Wavers - MSN
FDA asks Novavax for commitment on post-approval studies for COVID vaccine - 1470 & 100.3 WMBD
Novavax Says COVID Vaccine Application 'Approvable' - marketscreener.com
Novavax (NVAX) Awaits FDA Approval Following Additional Data Request | NVAX Stock News - GuruFocus
Novavax stock jumps on positive FDA discussions By Investing.com - Investing.com Canada
Novavax’s Biologics License Application Nears Approval - TipRanks
Novavax reveals FDA request for additional data By Investing.com - Investing.com India
Novavax says FDA has requested additional data for COVID vaccine after approval - TradingView
Novavax reveals FDA request for additional data - Investing.com
Novavax Inc To Engage With FDA To Address Pmc Request - marketscreener.com
0.24%
36.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):